Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
86.51M | 92.62M | 81.46M | 120.55M | 119.44M | 176.21M | Gross Profit |
54.82M | 57.41M | 38.84M | 69.08M | 68.79M | 118.39M | EBIT |
-31.14M | -22.13M | -36.82M | -15.83M | -29.18M | 3.76M | EBITDA |
-22.92M | -3.58M | -17.05M | 21.82M | -4.35M | -2.66M | Net Income Common Stockholders |
-45.13M | -36.70M | -49.49M | -11.91M | -31.95M | -19.79M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
288.85M | 19.35M | 12.44M | 17.58M | 18.05M | 15.09M | Total Assets |
899.89M | 587.85M | 618.28M | 693.77M | 711.82M | 634.80M | Total Debt |
0.00 | 321.10M | 318.42M | 320.91M | 345.50M | 261.18M | Net Debt |
-288.85M | 309.86M | 307.64M | 306.51M | 330.36M | 248.75M | Total Liabilities |
29.33M | 378.52M | 378.37M | 391.97M | 392.24M | 297.74M | Stockholders Equity |
834.59M | 208.84M | 239.38M | 301.59M | 318.28M | 332.37M |
Cash Flow | Free Cash Flow | ||||
-11.17M | 5.62M | -3.79M | 23.65M | -53.16M | -146.21M | Operating Cash Flow |
-10.51M | 6.29M | 402.00K | 23.99M | 10.65M | 16.65M | Investing Cash Flow |
-661.00K | -585.00K | -2.09M | 15.20M | -63.72M | -161.98M | Financing Cash Flow |
16.05M | -4.87M | -93.00K | -41.67M | 55.34M | 95.09M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | $115.32B | 8.48 | 3.52% | 5.72% | -3.04% | -20.01% | |
66 Neutral | $7.91B | 21.96 | -0.91% | 3.84% | -8.10% | -108.48% | |
66 Neutral | $4.51B | 12.29 | 5.40% | 248.53% | 4.14% | -12.41% | |
56 Neutral | HK$1.90B | 18.26 | 3.10% | 3.03% | 9.38% | -41.33% | |
43 Neutral | $4.84B | ― | -4.20% | 2.44% | -10.06% | 86.09% | |
40 Underperform | HK$194.34M | ― | -21.53% | ― | -6.77% | -26.30% |
Hin Sang Group (International) Holding Co. Ltd. announced the resignation of Ms. Wong Wai Ling as a non-executive director, effective April 1, 2025, due to other business engagements. The company expressed gratitude for Ms. Wong’s contributions during her tenure and confirmed there are no disagreements or issues related to her departure that need to be addressed with the Hong Kong Stock Exchange or shareholders.
Hin Sang Group (International) Holding Co. Ltd. has announced the composition of its board of directors effective from April 1, 2025. The board includes a mix of executive, non-executive, and independent non-executive directors, reflecting a diverse leadership structure. The company has also established three standing board committees, namely the Audit, Nomination, and Remuneration Committees, with specific directors assigned roles as members or chairpersons. This announcement is significant for stakeholders as it outlines the governance framework and leadership roles that will guide the company’s strategic direction and operational oversight.
Hin Sang Group has entered into a supplemental agreement with Fullshare, altering the funding commitments for their joint venture focused on health products and services. The agreement relieves both parties from further funding obligations, with the company maintaining that this change will not adversely impact its business or financial position.